Spine

KICVentures Appoints Ken Yamada as President & CEO of AxioMed

BOSTON (PRWEB) MARCH 18, 2020

AxioMed, LLC is dedicated to advance the standard of care for patients with degenerative spine conditions by progressing spine technology beyond fusion and first generation artificial discs and has announced Ken Yamada as its President and Chief Executive Officer succeeding Kingsley Chin, MD., who is stepping down to focus on further expanding KICVentures and its healthcare portfolio.

“Mr. Yamada is a seasoned executive with 25 years of medical device industry experience and a strong track record of success specifically in orthopedic and neurosurgery global markets. Mr. Yamada played a critical role in laying the commercial foundation of LDR’s Mobi-C cervical disc that was acquired by ZimmerBiomet for $1.1 Billion. He also brings executive experience that helped expand the Asian footprint for Arthrex, an orthopedic company generating over $2 billion in revenues. Ken has successfully raised millions in investment capital as the Chief Business Development Officer of KICVentures and is well-positioned to now lead AxioMed and bring this disc to the global market”, says Kingsley Chin, MD.

“It’s an exciting time to assume the leadership of AxioMed as we plan to launch the disc to international markets next year, along with our viscoelastic lumbar disc in the US, and begin a multilevel cervical clinical trial. AxioMed has optimized a proprietary polymer that mimics the human disc and will change the lives of those suffering with spine pain. My vision is to have every patient in the world with back or neck pain get access to this revolutionary technology and regain their mobility to lead a normal active lifestyle. As the custodian of this solution, it is our moral imperative to get this into the hands of surgeons to treat their patients” commented Mr. Yamada.

AxioMed has received it’s CE mark for its Freedom® Artificial Cervical Disc, and has developed distribution partners in key international markets with high anticipation for its initial launch.

About AxioMed
AxioMed is a KICVentures medical device portfolio company, with the only viscoelastic single-piece spinal disc replacement technology for motion preservation solutions of the cervical and lumbar spine with its headquarters in Boston, MA, USA. http://www.axiomed.com

About KICVentures
KICVentures is a private investment holding company founded by Harvard-trained Orthopedic Surgeon & Professor Dr. Kingsley R. Chin that has built deep spine industry knowledge and an infrastructure platform to pursue complete buyouts of small cap medical device companies since 2005 with a niche focus in outpatient spine surgery, and is headquartered in Boston, MA. http://www.kicventures.com

Print Friendly, PDF & Email
Tags

Josh Sandberg

Josh Sandberg is the President and CEO of Ortho Spine Partners and sits on several company and industry related Boards. He also is the Creator and Editor of OrthoSpineNews.

Related Articles

Back to top button
Close